Review a Clinical AI Tool Before Purchase, After Changes, and When Something Goes Wrong

An ambient documentation tool can affect more than the wording of a note. Its output may influence medication lists, orders, summaries, follow-up tasks, and later readers’ understanding of what the patient said. A useful organizational review therefore follows a statement from its source through the places where it can influence care.

This guide offers a procurement question bank, a fictional evaluation, and a change-review worksheet. It describes a clinical review of meaning and workflow. Software assurance, privacy and security, regulatory classification, legal consent, accessibility, contracting, and statistical validation require their own qualified reviewers.

Define the intended task before evaluating the product

Write a short intended-use statement: who will use the system, for what encounter types, with which inputs, and which outputs may influence care. “Improves documentation” is too broad. “Produces a draft outpatient note from the encounter audio for clinician correction before signing” is a testable starting description. If the system also suggests codes, populates lists, or generates patient messages, treat those as additional functions.

Ask the vendor and implementation team to distinguish available functions from functions enabled locally. Obtain versioned documentation rather than relying on a sales demonstration. The NIST Generative AI Profile is voluntary risk-management guidance; it cautions against generalizing performance from narrow anecdotal evaluations. A few convincing demonstrations do not establish a population error rate or safety certification.

Procurement questions that reveal clinical dependencies

Use these questions before deciding what a pilot must examine:

• What sources can the system read, and which sources are excluded or delayed?
• How are patient statements distinguished from caregiver, interpreter, and clinician statements?
• What happens to uncertainty, negation, competing explanations, and a patient’s conditional agreement?
• Can a reviewer inspect the basis of a disputed assertion within the authorized workflow?
• Which downstream fields are populated, and which corrections propagate automatically?
• Who can disable a function, revert a configuration, or prevent unsigned content from being reused?
• What notice, evidence, and support accompany a product or model change?

Answers should identify a responsible person and an available document or demonstration. “The clinician checks everything” leaves unresolved whether the interface and work schedule make that check possible. “The model learns” does not explain whether a particular correction changes a patient’s record, future outputs, or neither.

Define the source packet and the comparison method

Before reviewing output, specify the permitted source packet: encounter transcript or audio where lawfully available, relevant chart material, clinician-entered context, and the configured instructions. Record what is missing. A generated statement cannot fairly be called unsupported if the reviewer has not established what information the system actually received.

For each assertion, classify the comparison as supported, contradicted, not established by the available packet, or not assessable. Keep stylistic preferences separate from clinically meaningful discrepancies. A shortened sentence may preserve meaning; a change from “unable to obtain” to “declined” may change the plan’s interpretation.

Have the clinical reviewer explain potential significance without claiming injury occurred. A technical reviewer should separately investigate where the output originated and how it moved. The ONC SAFER organizational-responsibilities resource is a useful organizational starting point, not a substitute for those distinct assessments.

Fictional worked evaluation: a correction that stops too soon

Fictional case and invented product. A clinic evaluates “Scribe Example,” version A, using a deliberately constructed encounter packet. The patient says that a recommended procedure is acceptable but the proposed appointment conflicts with caregiving. The generated note states that the patient refused. The clinician corrects that sentence before signature.

The exercise then inspects the associated task list. A separate field still says “patient declined—close referral.” The note is now accurate, but the workflow remains wrong. The team changes the local process so the reviewing clinician can see and correct the task disposition before the encounter is considered complete. It then repeats the same fictional scenario and several different communication scenarios.

In the next teaching branch, version B changes the location of the task-disposition field. A previously useful review step no longer exposes it. That change triggers a targeted recheck of correction propagation and the reviewer interface.

No real product was tested, and these branches establish no frequency of error. They demonstrate why evaluation should examine the clinical pathway affected by an output and why an interface change can matter even when the model’s name remains unchanged.

Make human review an observable process

Identify which person reviews which outputs, at what point, using what source material. Ask how the workflow handles a long encounter, an interrupted review, a different language, a patient correction, and a clinician who cannot finish before leaving. Decide what remains inaccessible to downstream users while review is incomplete.

Reviewers need a practical way to flag uncertainty and correct material errors without silently rewriting historical records. Track whether correction reaches instructions already sent, orders already placed, and summaries already generated. The appropriate correction process depends on the record and organizational policy; do not assume a note edit automatically repairs all downstream actions.

The clinical question is whether the review can reasonably detect and address the selected risk. The legal allocation of responsibility among clinician, employer, vendor, and other actors needs a separate facts-and-law analysis.

Change-review worksheet and release decision

Use one worksheet for each proposed change, including configuration changes. Keep the earlier version and decision record accessible under the organization’s retention rules.

Set the decision criteria before viewing favorable examples. A material unresolved discrepancy may justify holding a particular function while other functions remain under separate review. The decision should name the affected use, evidence, uncertainty, and next assessment. Avoid declaring the entire system either “safe” or “unsafe” from an unrepresentative handful of encounters.

Preserve an incident without overstating its cause

An incident record should separate the reported concern, observed output, expected meaning, clinical consequence if known, and hypotheses requiring investigation. Record relevant version and configuration information, available source material, correction history, and affected downstream records through approved preservation procedures.

NIST’s profile discusses post-deployment monitoring and recording errors and near misses. Applying that approach does not mean every discrepancy is a software defect or that every reported incident establishes causation. A missing input, local configuration, user action, or interface misunderstanding may contribute. Preserve competing explanations until the evidence supports a conclusion.

Questions readers ask

Does a physician’s review establish that the software is validated?

No. Clinical review can assess meaning and practical consequences within the reviewer’s expertise. Population performance, technical reliability, security, and regulatory status require suitable methods and additional expertise.

Must the organization repeat every evaluation after every update?

Define a change-assessment process. The nature and scope of the change determine which functions and risks require rechecking. Record the rationale rather than assuming either that nothing changed or that every prior result is unusable.

Can the team use real encounter recordings in a pilot?

That requires prior determination of lawful collection, permissions, approved storage, access, retention, and vendor handling. Fictional packets can teach the method without resolving or bypassing those real-data obligations.

Related resources and sources

Existing foundations are clinical AI consulting scope, the healthcare AI dossier, and clinical governance. Continue with EHR technical and clinical questions, process-measurement methods, and patient digital-health access.

Source and scope note. Primary sources: NIST AI 600-1 and ONC’s organizational SAFER resource, linked above. The procurement questions and fictional evaluation are educational tools, not product findings, certification, or an advertised technical service. Prepared November 5, 2026 Pacific.